The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Complete neoadjuvant therapy in rectal cancer (CONTRE): A Brown University Oncology Research Group phase II study.
Kimberly Perez
No relevant relationships to disclose
Nishit Shah
No relevant relationships to disclose
Victor Pricolo
No relevant relationships to disclose
Matthew Vrees
No relevant relationships to disclose
Leslie Roth
No relevant relationships to disclose
Steven Schechter
No relevant relationships to disclose
Adam Klipfel
No relevant relationships to disclose
Thomas A. DiPetrillo
No relevant relationships to disclose
Timothy J. Kinsella
No relevant relationships to disclose
Nicklas B. E. Oldenburg
No relevant relationships to disclose
Murray B. Resnick
No relevant relationships to disclose
Kayla Rosati
No relevant relationships to disclose
Howard Safran
No relevant relationships to disclose
William M. Sikov
No relevant relationships to disclose